baber/WOPTO huggingface dataset:
Patent AT-E373464-T1 (AT)
Inventor: AIACHE JEAN-MARC
IPC: A61K9/70
Filed: 2002-07-23
Granted: 2007-10-15
Abstract: Prolonged release mucosal bioadhesive therapeutic compositions (I) comprise: (a) natural protein; (b) active material (>= 50 wt.%) (>= 80 % dissolves within 8 hours); (c) therapeutic bioadhesive (>= 20 %); (d) hydrophilic polymer (10 - 20 %); (e) compression excipients; (f) alkali metal alkyl sulfate (3.5 - 10 %); and (g) sugar monohydrate (0.1 - 1 %). ACTIVITY : Fungicide. MECHANISM OF ACTION : None given in the source material.
Patent AT-E355834-T1 (AT)
Inventor: MOINET GERARD
IPC: A61P3/10
Filed: 2002-11-06
Granted: 2007-03-15
Abstract: The present invention relates to the use of a 4-oxobutanoic acid derivative for the preparation of a pharmaceutical composition for treating inflammation.
Patent AT-E458544-T1 (AT)
Inventor: BROENS LUTE
IPC: B01D29/15
Filed: 2002-11-15
Granted: 2010-03-15
Abstract: A filter module provided with a housing ( 3 ) having an inlet ( 6 ) for a liquid to be filtered and an outlet ( 10 ) for filtered liquid, with a first filter element ( 7 - 9, 12 ) accommodated in the housing ( 3 ), in the form of a porous mass provided with a central through-opening, to which the inlet ( 6 ) connects, and with a second filter element ( 1 ) accommodated in the housing ( 3 ) in the form of a number of lengths of tube-shaped filtering membrane ( 2 ), which together define a cylinder shape, which cylinder shape, at at least one extremity, between the open-ended filter membranes ( 2 ), is filled up with a sealing material, to which extremity the outlet ( 10 ) connects. The inlet ( 6 ) connects to the central through-opening of the first filter element ( 7 - 9, 12 ), which is surrounded by the second filter element ( 1 ), which has the form of a tubular casing obtained by winding from tube-shaped filtering membrane ( 2 ).
Patent AT-E468129-T1 (AT)
Inventor: BUSH ASHLEY
IPC: A61K45/00
Filed: 2002-09-26
Granted: 2010-06-15
Abstract: The present invention relates generally to a method of modulating glutathione metabolism in the central nervous system of mammals and to agents for use therein. More particularly, the present invention relates to a method of up-regulating glutathione metabolism in the central nervous system by up-regulating levels of glutathione precursor molecules. The method of the present invention is particularly useful, inter alia, in the treatment and/or prophylaxis of conditions characterised by aberrant, unwanted or otherwise inappropriate central nervous system oxidation homeostasis including, but not limited to, schizophrenia.
Patent AT-E290958-T1 (AT)
Inventor: FIORAVANTI MORENO
IPC: B60B1/04
Filed: 2002-10-09
Granted: 2005-04-15
Abstract: A bicycle wheel, particularly for racing and mountain bicycle, comprising a hub (3) that has two flanges (4,5) connected to a rim (2) by way of wire spokes, said wire spokes forming a first plurality of radial elements (6), which are mutually angularly equidistant by a preset angle and connect said rim (2) to the first flange (4) of said hub (3), and a second plurality of radial elements (6), which are mutually angularly equidistant by said angle, are offset by half of said angle with respect to said first plurality and connect said rim (2) to the second flange (5) of said hub (3), each one of said radial elements (6) being constituted by a first wire spoke (7) and a second wire spoke (8) which are substantially parallel.
Patent AT-E333066-T1 (AT)
Inventor: SCHERER OSWALD
IPC: F16L55/1645
Filed: 2003-02-06
Granted: 2006-08-15
Abstract: The spray pistol (1) is particularly for spraying abrasive material or media containing abrasive material and has a valve (8) operable by a nozzle needle and located in the pistol head (2) near the nozzle aperture. An operating and setback device (17,23) is provided for the nozzle needle.  The nozzle (8) has a channel (9) issuing in the nozzle aperture of the spray pistol, in which the nozzle needle is displaceably located. A lateral hole feeds media into the nozzle channel. The hole is closable by the nozzle needle and the length of the needle is such that in the rest state it terminates at least with the nozzle aperture of the spray pistol. The nozzle needle is of hard metal or ceramic.
Patent AT-E286629-T1 (AT)
Inventor: LINDEMANN KAI-UWE
IPC: H01R4/40
Filed: 2003-04-11
Granted: 2005-01-15
Abstract: A contact (3) has a tip (8) whose conical surface (5) is at a vertical angle. A clamping shoulder (9) has a surface (11) with angle (beta) to vertical side facing the surface (5). The contact is screwed into a chamber (4) and cable strand (15) inserted, such that minimum over lap (13) remains between conical surfaces.
Patent AT-E386606-T1 (AT)
Inventor: SCHUMACHER JOERG
IPC: B23K26/04
Filed: 2003-04-12
Granted: 2008-03-15
Abstract: Arrangement has seam position component (1) for changing the seam position, a laser welding process component (2) having two integrated laser welding sources for producing a single laser welding seam, a seam position regulating unit (3) having an outlet (31) connected to seam position component, and a sensor (4) installed on or close to laser welding process component and connected to inlet (32) of seam position regulating unit.  The seam position regulating unit has a switch (S) for converting an information comparison of the sensor information (A) with theoretical information (B) and for generating a regulating size (D) for the process parameters.  An Independent claim is also included for a process for the regulation of the seam position of a profile joined by welding using the above arrangement.
Patent AT-E364764-T1 (AT)
Inventor: HUENTING HARALD
IPC: E04B9/16
Filed: 2003-04-24
Granted: 2007-07-15
Abstract: The device for the connecting of two rails comprises at least two side sections (20,21) to which is connected a center section (22). At least one locking element (10,11) is installed in the region of each side section and snap-locks on the edge section of the associated side wall of the first rail or on a transition section (25) between the associated side wall and a bottom connecting the two side walls and/or the bottom of the first rail.
Patent AT-E414715-T1 (AT)
Inventor: VALENTA RUDOLF
IPC: C12N15/09
Filed: 2003-09-04
Granted: 2008-12-15
Abstract: The present invention relates to non-naturally occurring polypeptides derived from fish allergens such as parvalbumin Cyp c 1.01 from carp. The polypeptides display reduced allergenic activity and are useful as allergy vaccines for treatment of sensitized allergic patients and for prophylactic vaccination.
Patent AT-E438825-T1 (AT)
Inventor: KLUTH MANFRED
IPC: E04B5/46
Filed: 2003-09-16
Granted: 2009-08-15
Abstract: A process to illuminate objects, especially moving objects comprises many controllable light sources (12) with sensors (15) to detect moving or stationary objects, e.g., persons (2) and a sensor control unit (17). The object and its position are determined by the sensors and the lights controlled to give maximum illumination at that point.  Independent claims are also included for the lighting unit with lights, sensors and a control unit for the above process.
Patent AT-E324926-T1 (AT)
Inventor: MUELLER-HERTMANN HERBERT
IPC: A61N1/30
Filed: 2003-10-24
Granted: 2006-06-15
Abstract: Method for creating at least an electric contact area on a polymer doped with conduction material in which a contact material (10, 11) is applied to the polymer. Said material has a lower specific resistance than the polymer at 23 degrees C. The material used is a metallic suspension, especially silver, which is placed in close conducting contact with the conduction material. An independent claim is made for a molded body made from polymer doped with conducting material.
Patent AT-E295203-T1 (AT)
Inventor: ERBEL STEPHAN
IPC: A61B6/04
Filed: 2001-06-06
Granted: 2005-05-15
Abstract: A patient bed (3) may be arranged both at a planning couch (8) for image detection within the framework of treatment planning as well as at a radiotherapy table (1). A reference member is provided on the patient bed, with which the position of the immobilized patient and/or marked points on the surface of the patients body is determined with respect to the patient bed.  An Independent claim is also included for a patient position method.
Patent AT-E459782-T1 (AT)
Inventor: KOERKEMEYER KARSTEN
IPC: E21B7/04
Filed: 2003-10-22
Granted: 2010-03-15
Abstract: The pipe sections (1, 2) moved horizontally in mining or tunneling by strong propelling forces are joined with ring-shaped elements (3) made of a strong material, which can be elastic and filled with a suitable fluid. The cross-section of each of the elements (3) is of a roughly rectangular shape in order to form contact surfaces permanently touching the edges of the adjacent pipe sections (1, 2). When the arrangement (1, 2, 3) is moved the motion of the fluid compensates the differences in the distances between the pipes (1, 2).
Patent AT-E337085-T1 (AT)
Inventor: ENOMURA MASAKAZU
IPC: B01F7/00
Filed: 2003-07-16
Granted: 2006-09-15
Abstract: A processing apparatus for fluid with a simple structure, high productivity, ability of precise dispersion, emulsification and grinding, is provided. <??>The apparatus of the present invention comprises at least two processing faces of a first face and a second face, both of which are arranged in a tight-closed passage, and positioned opposite to each other to constitute part of said passage, and a contact pressure applying mechanism for putting both faces 1, 2 into closed contact with each other, wherein the rotation of the second processing face 2 in respect of the first processing face 1 may cause dispersion or emulsification of the fluid to be processed between both processing faces 1, 2. The first and second processing faces 1, 2 are placed in closed contact with or adjacent to each other by means of said contact pressure applying mechanism, and the fluid to be processed is actuated by said rotation to pass between the first and second processing faces 1, 2, as it is forming fluid films between said processing faces 1, 2, so that said fluid will be emulsified or dispersed to a desired extent. <IMAGE>
Patent AT-E377347-T1 (AT)
Inventor: CHIANG CHING-CHUNG
IPC: H01R9/26
Filed: 2003-09-02
Granted: 2007-11-15
Abstract: In a controller module (3), a connecting seat (81) of a circuit unit (8) is disposed in a hollow case (5), is exposed from an open end (51) of the case (5), is coupled electrically to a control circuit (80), and is formed with first conductive contacts (811). A terminal block (9), mounted detachably in a cover member (6), has a mounting side (94) provided with second conductive contacts (941) that are connected electrically, respectively and removably to the first conductive contacts (811), an input side (93) opposite to the mounting side (94) and formed with input insertion holes (931) for insertion of external terminals (110), and a top side (91) formed with probe insertion holes (92) for insertion of test probes (4). A positioning member (100) is mounted pivotally on the cover member (6) for positioning the terminal block (9) on the connecting seat (81).
Patent AT-E424802-T1 (AT)
Inventor: GATELLIER NATHALIE
IPC: A61K8/19
Filed: 2003-01-24
Granted: 2009-03-15
Abstract: The invention relates to cosmetic compositions characterised in comprising at least pozzuolana as binding agent. The compositions can further comprise saline solutions, thermal waters, essential oils and similar, including oligoelements, salts or other beneficial principals, seaweed extracts, marine salt and similar, sulphur and, optionally, pharmaceutically-active agents. The above are at least partly absorbed and enter exchange on the pozzuolana. Of application in cremes, lotions, oils, exfoliating soaps and similar.
Patent AT-E387444-T1 (AT)
Inventor: ZHANG HAN-CHENG
IPC: A61K31/437
Filed: 2003-05-06
Granted: 2008-03-15
Abstract: The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.
Patent AT-E362285-T1 (AT)
Inventor: HUPP JUERGEN
IPC: A61B5/00
Filed: 2003-02-12
Granted: 2007-06-15
Abstract: A central processing unit for communicating with at least one auxiliary unit, comprising a transmitter unit (12) for the transmission of a series of multi-frames and a processor (14) for generating the series of multi-frames. A multi-frame in the series of multi-frames comprises a control frame and a useful frame. The control frame is provided with sleep mode information for the at least one auxiliary unit. The sleep mode information indicates the period of time in which the at least one auxiliary unit should be in said sleep mode. Said period of time is greater than or equal to the duration of the at least one useful frame of the multi-frame. Auxiliary units can thus be placed in a sleep mode in a deterministic manner and for any desired period of time so as to obtain as low power consumption as possible in said auxiliary unit.
Patent AT-E396740-T1 (AT)
Inventor: GUZMAN CARLOS
IPC: A61K39/39
Filed: 2003-04-03
Granted: 2008-06-15
Abstract: The use of lipopeptides or lipoproteins (I), designated macrophage activating lipopeptides (MALP), as a mucosal adjuvant for therapeutic or prophylactic vaccination viathe mucosa is new. Also claimed is the use of (I) (with some specific compounds excepted) as adjuvants for non-mucosal vaccination. The use of a lipopeptide or lipoprotein of formula (I) is claimed as a mucosal adjuvant for therapeutic or prophylactic vaccination viathe mucosa. [Image] R 1, R 27-25C alkyl, 7-25C alkenyl or 7-25C alkynyl; X : S, O or CH 2; R 3, R 4H or Me; and Y : sequence of 1-25 (preferably 12-25) amino acid residues, which is physiologically acceptable and not in itself immunogenic in the species to be treated; provided that the asterisked C atom has absolute R-configuration if X = S. An independent claim is also included for the use of (I) as adjuvant for non-mucosal vaccination, with the additional proviso that (I) is other than an S-(2,3-diacyloxypropyl)-cysteine peptide (I') of the sequence Asp-hcGly-Asn-Asn-Asp-Glu-Ser-Asn-Ile-Glu-Ser-Phe-Glu-Lys-Glu-Lys, where the amino acids in position 2 and optionally 3 at the N-terminal are optionally absent and/or 1 or 2 aminoacids may be deleted from the C-terminal. ACTIVITY : Immunostimulant. Mice were immunized intranasally on days 0, 7 and 14 with 40 mu g beta -galactosidase (as model antigen) or a mixture of 40 Microg beta -galactosidase and 1 Microg MALP-2 (Ia) as adjuvant. On day 28 serum samples were analyzed by enzyme-labeled immunosorbent assay for the beta -galactosidase-specific antibody titer. The titers, in absorption value units (OD 405 nm), were 0.25 in the absence of (Ia) and 0.30 in presence of (Ia). MECHANISM OF ACTION : None given.
Patent AT-E486626-T1 (AT)
Inventor: HADZIC ADMIR
IPC: A61M5/14
Filed: 2003-05-09
Granted: 2010-11-15
Abstract: An objective and reproducible system for, and method of, monitoring and/or controlling the pressure during nerve blockage injection, especially by less experienced personnel, is provided in order to decrease the possibility of intraneuronal injection. More specifically, the present invention employs a pressure sensing and/or limiting device located between an injection device (typically a syringe) and a nerve block needle whereby injection pressure during a nerve block injection can be easily and objectively monitored, thereby allowing the operator to monitor the injection pressure and/or injection speed during a nerve blockage injection procedure and to take appropriate corrective actions if abnormal pressure conditions are observed.
Patent AT-E499920-T1 (AT)
Inventor: LANGEN GUENTER
IPC: A61F13/00
Filed: 2003-10-24
Granted: 2011-03-15
Abstract: A coating composition is described for the anti-adhesive coating of wound dressings, comprising a nanosol that contains silica and at least one hydrophobic organic silicon compound, anti-adhesive layers prepared therefrom, coated wound dressings and methods for their manufacture.
Patent AT-E354918-T1 (AT)
Inventor: UCHIDA NOBUYUKI
IPC: G06F13/00
Filed: 2003-07-09
Granted: 2007-03-15
Abstract: Techniques for converting short messages between different formats (e.g., from GSM SMS to CDMA SMS) such that pertinent control information is retained without changing the fundamental structure of these message formats. A new value is defined for the Msg Encoding field in the User Data subparameter of the CDMA SMS message to indicate that the content of this message is an encapsulated GSM SMS message. The Message Type field in the User Data subparameter may be used to carry data coding scheme information for the encapsulated GSM SMS message. At a recipient mobile station, the value in the Msg Encoding field is checked to determine whether or not the CDMA SMS message includes an encapsulated GSM SMS message. If the answer is yes, then the user data in the CHARi fields of the CDMA SMS message is processed based on the data coding scheme information from the Message Type field.
Patent AT-E504074-T1 (AT)
Inventor: CHISTYAKOV ROMAN
IPC: H01J37/32
Filed: 2003-10-28
Granted: 2011-04-15
Abstract: Magnetically enhanced plasma processing methods and apparatus are described. A magnetically enhanced plasma processing apparatus according to the present invention includes an anode and a cathode that is positioned adjacent to the anode. An ionization source generates a weakly-ionized plasma proximate to the cathode. A magnet is positioned to generate a magnetic field proximate to the weakly-ionized plasma. The magnetic field substantially traps electrons in the weakly-ionized plasma proximate to the cathode. A power supply produces an electric field in a gap between the anode and the cathode. The electric field generates excited atoms in the weakly-ionized plasma and generates secondary electrons from the cathode. The secondary electrons ionize the excited atoms, thereby creating a strongly-ionized plasma. A voltage supply applies a bias voltage to a substrate that is positioned proximate to the cathode that causes ions in the plurality of ions to impact a surface of the substrate in a manner that causes etching of the surface of the substrate
Patent AT-E394679-T1 (AT)
Inventor: ZEIHER ANDREAS
IPC: C07K14/705
Filed: 2003-11-10
Granted: 2008-05-15
Abstract: Analysis of samples associated with acute cardiovascular disease by determining the concentration of at least one of the markers soluble CD40 ligand (sCD40L); PAPP-A (pregnancy-associated plasma protein-A) and placental growth factor (PlGF), and comparing the result with reference values or results from reference samples. Analysis of samples associated with acute cardiovascular disease by determining the concentration of at least one of the markers soluble CD40 ligand (sCD40L); PAPP-A (pregnancy-associated plasma protein-A) and placental growth factor (PlGF), and comparing the result with reference values or results from reference samples. Optionally at least one of the additional markers troponin T (TnT), MPO (not defined), NT-pro-BNP (brain natriuretic peptide), VEGF (vascular endothelial growth factor), BNP or additional inflammation markers are also determined and compared. An independent claim is also included for a diagnostic kit comprising reagents for performing the new method, optionally also other components and/or auxiliaries.
Patent AT-E495954-T1 (AT)
Inventor: GAERTNER VOLKER
IPC: B60T8/172
Filed: 2003-11-14
Granted: 2011-02-15
Abstract: A velocity and acceleration are measured ( 14 ) in a method for determining a vehicle reference velocity, said vehicle reference velocity being used for determining and selecting a suitable transmission ratio. If a measured acceleration (a<SUB>ist</SUB>) exceeds ( 16 ) a maximally possible acceleration (a<SUB>max</SUB>), a vehicle reference acceleration (a<SUB>ref</SUB>) is determined depending on said exceeding. For this purpose, an acceleration correction value (BKF) is calculated ( 22 ) by means of which acceleration correction value a vehicle reference acceleration is calculated ( 24 ). The vehicle reference velocity (v<SUB>ref</SUB>) is determined ( 26 ) by means of the vehicle reference acceleration (a<SUB>ref</SUB>). A gearbox transmission ratio is determined ( 20 ) by means of the determined vehicle reference velocity. This branch of the procedure represents the case in which at least one wheel equipped with sensors slips.
Patent AT-E499094-T1 (AT)
Inventor: VERMEER CEES
IPC: A23L1/304
Filed: 2003-09-01
Granted: 2011-03-15
Abstract: Vitamin K is effective in counteracting cardiovascular disorders such as the reduction in arterial elasticity normally associated with the aging process. A pharmaceutical composition or nutritional formulation comprising vitamin K can be used to combat age-related stiffening of the arteries, and the consequences thereof, namely pulmonary congestion, hypertension, left ventricular hypertrophy, congestive (right sided) heart failure, left sided or left ventricular failure, chronic cardiac failure, angina pectoris, myocardial infarction, Mönckeberg's sclerosis and stroke. In various embodiments, vitamin K can also be used to reduce or reverse calcification of a blood vessel in pre-existing cardiovascular disorders such as arteriosclerosis.
Patent AT-E470939-T1 (AT)
Inventor: BANDYOPADHYAY SUMANDA
IPC: C08K3/04
Filed: 2003-06-12
Granted: 2010-06-15
Abstract: A polymeric composite comprises a polymeric resin; an electrically conductive filler; and a polycyclic aromatic compound, in an amount effect to increase the electrical conductivity of the polymeric composition relative to the same composition without the polycyclic aromatic compound. The addition of the polycyclic aromatic compound in addition to a conductive filler imparts improved electrical and mechanical properties to the compositions.
Patent AT-E302724-T1 (AT)
Inventor: KRAEMER THILO
IPC: B65G47/84
Filed: 2004-01-19
Granted: 2005-09-15
Abstract: The device for the braking and shortening of the transporting distance of objects coming from a feed device (1) has an elongated plate (4) which is installed to move either rotatably around a floating axis (5) or longitudinally in the vertical direction, and the width of which is smaller than the width of the chamber of a transporting device. The plate extends parallel to the plane covered by the entry opening into the chamber and protrudes into the chamber from the top, and onto this plate run the individual objects which are braked thereupon.
Patent AT-E485886-T1 (AT)
Inventor: YAMADA KENJI
IPC: B01J8/20
Filed: 2004-06-15
Granted: 2010-11-15
Abstract: A process for producing inorganic spheres, which comprises injecting an aqueous liquid containing an inorganic compound into a laminar flow of an organic liquid which runs at a flow rate of from 0.001 to 2 m/s in a flow path through a porous membrane to form a W/O type emulsion and solidifying the aqueous liquid containing an inorganic compound in the W/O type emulsion.
Patent AT-E359422-T1 (AT)
Inventor: SALICE LUCIANO
IPC: E05D3/06
Filed: 2004-05-13
Granted: 2007-05-15
Abstract: A furniture hinge comprising an arm (1) for fastening to a piece of furniture (4) and a part (7) for fastening to a door (11), where said items are joined by two rockers (5, 6) to form an articulated quadrilateral that allows rotation; and a V-shaped spring (8), placed near an end of a rocker (6), with an arm (8') of the spring resting on the arm (1) and the second arm (8") of the spring resting on a protrusion or cam of the rocker (5) to create a lever arm that compresses the spring (8) producing a moment in the opening or closing direction of the door (11), depending on the shape the protrusion (9', 9", 9"') found on the rocker (5). <IMAGE>